CEFAZOLINE PANPHARMA 1 g/5 ml, powder and solution for parenteral use (IV) 25 bottles of 1 g, CIP 3400955603993
Active ingredients: Cefazolin, Cefazolin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solution for parenteral use25 bottles of 1 g, CIP 3400955603993intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFAZOLINE PANPHARMA 1 g/5 ml, poudre et solution pour usage parentéral (IV)
- Pharmaceutical form
- poudre et solution pour usage parentéral
- Route of administration
- intraveineuse
- Presentation description
- 25 flacon(s) en verre de 1 g - 25 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69258056CIP75560399CIP133400955603993Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFAZOLINE SODIQUEpoudre | — | SA |
| CÉFAZOLINE BASEpoudre | 1 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.